Joe Kiani, founder of a company that he built into billions of dollars of sales, was ousted from the board, according to an ...

Masimo Corp shareholders elected both director candidates proposed by veteran activist investor Quentin Koffey's hedge fund Politan Capital Management, in one of the most contentious boardroom battles ...

Politan Capital Management (together with its affiliates, "Politan"), a 9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ: MASI), today commented on the outcome of the Company's ...

Masimo shareholders today will decide on a bitter proxy fight between the company's founder and CEO Joe Kiani and Politan ...

Masimo MASI recently announced that a U.S. court has found Politan Capital and its managing partner, Quentin Koffey, guilty ...

Koffey was elected to Masimo’s board in June 2023 along with Politan-backed candidate Michelle Brennan, a former Johnson & Johnson executive. The hedge fund argued that Masimo’s $1 billion acquisition ...

In its “lopsided” report in support of Politan’s nominees, Institutional Shareholder Services, Inc. (ISS) stated:1 Similarly, in an analysis described as ...

Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation ... Inc. (ISS) stated: 1 “Moreover, like last year, Kiani and his cohort ...

Politan Capital Management (together with its affiliates, “Politan”), an 8.9% shareholder of Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), today sent a letter to ...

Masimo (MASI) closed the last trading session ... the most optimistic analyst expects the stock to surge 49.1% to reach $170. It's very important to note the standard deviation here, as it helps ...

1 Masimo SET ® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates, 2 improve CCHD screening in newborns 3 and, when used for continuous monitoring with ...